Division of Cardiac Surgery, Heart Centre Siegburg-Wuppertal, University Witten-Herdecke, Germany.
Department of Cardiac Surgery, University Hospital Bonn, Bonn, Germany.
Eur J Cardiothorac Surg. 2022 Jul 11;62(2). doi: 10.1093/ejcts/ezac311.
Extensive infective endocarditis (IE) stays a serious life-threatening disease with high mortality and morbidity. The aim of this study is to analyse our experience with our modified surgical technique for extensive IE during the last 4 years.
Between March 2017 and February 2021, all patients with extensive IE required our modified technique consisting of a radical surgical resection of all infected cardiac tissues, the replacement of infected valves and a reconstruction of the intervalvular fibrous body, the aortic root and the left ventricular outflow tract with modified elephant trunk were included in this study.
Our modified technique was performed on 41 patients during the study period. The age median was 74 [interquartile range (IQR): 66.5-76.5] and 61.0% (n = 25) were female. Thirty-three patients (80.5%) were in New York Heart Association Class III-IV and 7 patients (17.1%) in cardiogenic shock. The median logistic European system for cardiac operative risk evaluation II as predicted risk of mortality was 35% (IQR: 28-78%). The median cardiopulmonary bypass time and cross-clamping time were 126 (IQR: 86.5-191) and 78 (IQR: 55.5-108) min, respectively. Intraoperative mortality and 30-day mortality were 4.8% (2 patients) and 19.5% (8 patients), respectively. Low cardiac output with necessity for mechanical support, stroke and new renal dialysis developed in 9.8% (4 patients), 17.1% (7 patients) and 22.0% (9 patients), respectively. New pacemaker implantation was noted in 39.0% (16 patients). Intensive care stay and hospital stay had medians of 6 (IQR: 5-12) and 14 (IQR: 12.5-20.5) days, respectively. One-year mortality and 4-year mortality were 34.1% (14 patients) and 39.0% (16 patients), respectively. Kaplan-Meier survival estimates were 60.3% (95% confidence interval: 46.2-78.6%) at 3 years.
Our modified technique can be performed in patients with extensive IE with acceptable early and mid-term morbidity and mortality. We believe that this technique is an available option for this ill-fated group of patients.
广泛感染性心内膜炎(IE)仍然是一种严重的危及生命的疾病,具有高死亡率和发病率。本研究的目的是分析我们在过去 4 年中采用改良手术技术治疗广泛 IE 的经验。
2017 年 3 月至 2021 年 2 月,所有需要我们改良技术的广泛 IE 患者均纳入研究,该技术包括彻底切除所有感染性心内膜组织、置换感染性瓣膜以及使用改良象鼻技术重建瓣下纤维体、主动脉根部和左心室流出道。
在研究期间,我们的改良技术共应用于 41 例患者。年龄中位数为 74 岁[四分位距(IQR):66.5-76.5],61.0%(n=25)为女性。33 例(80.5%)患者为纽约心脏协会(NYHA)心功能分级 III-IV 级,7 例(17.1%)为心源性休克。中位预测死亡率的欧洲心脏手术风险评估系统 II 评分(logistic EuroSCORE II)为 35%(IQR:28-78%)。体外循环时间和阻断时间的中位数分别为 126(IQR:86.5-191)和 78(IQR:55.5-108)分钟。术中死亡率和 30 天死亡率分别为 4.8%(2 例)和 19.5%(8 例)。9.8%(4 例)、17.1%(7 例)和 22.0%(9 例)患者分别出现低心排血量、需要机械支持、新发肾功能衰竭。39.0%(16 例)患者需植入新的起搏器。中位重症监护病房和住院时间分别为 6(IQR:5-12)和 14(IQR:12.5-20.5)天。1 年死亡率和 4 年死亡率分别为 34.1%(14 例)和 39.0%(16 例)。Kaplan-Meier 生存估计 3 年时为 60.3%(95%置信区间:46.2-78.6%)。
我们的改良技术可应用于广泛 IE 患者,其早期和中期发病率和死亡率可接受。我们认为该技术是这群不幸患者的一种可行选择。